Get started
Live feed
·
SECFilingvia Quantisnow
SCYNEXIS Inc. logo

SCYX: SCYNEXIS Inc. filed SEC Form 8-K: Leadership Update

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Historical context for SCYX

Across the 9 sessions after earlier SCYX headlines, the stock closed higher 4 times and lower 5 times, with a median move of 2.3% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

SCYX close-to-close change in the session after earlier headlines
SessionEarlier headlineSCYXSPY
Mar 31, 2026Poxel Announces the Sale of PXL770 to Scynexis for a Total Amount of up to $196 Millionand 2 other headlines that session+16.1%+2.9%
Mar 5, 2026SCYNEXIS Reports Full Year 2025 Financial Results and Provides Corporate Update+2.3%-0.6%
Feb 26, 2026SCYNEXIS Announces First Participants Dosed in a Phase 1 Single Ascending Dose and Multiple Ascending Dose Trial of Intravenous SCY-247-0.7%-0.6%
Jan 28, 2026SCYNEXIS Announces Presentations Highlighting the Potent Antifungal Activity of its Second-Generation Fungerp, SCY-247 Against Drug-Resistant Fungi, at the Inaugural Interdisciplinary Meeting on Antimicrobial Resistance and Innovation (IMARI)-3.2%-0.0%
Jan 21, 2026SCYNEXIS Receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designations for SCY-247+4.0%+1.2%
Dec 22, 2025SCYNEXIS Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement-2.3%+0.6%
Quantisnow market dataNASDAQ
SCYNEXIS Inc. logo
SCYX
SCYNEXIS Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2014
Get push alerts for SCYX

Follow SCYX and get a push notification the moment its next story breaks.

Full SCYX profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SCYX (SCYNEXIS Inc.) and more on Quantisnow.